Sep. 8 at 9:20 PM
Xtant Medical Holdings (NYSE-American:
$XTNT) announced that Sean Browne, CEO, and Scott Neils, CFO, will participate in the H.C. Wainwright 27th Annual Global Investment Conference.
Xtant Medical is a B2i Digital Featured Company. View the comprehensive profile at https://b2idigital.com/xtant-medical-1.
H.C. Wainwright’s 27th Annual Global Investment Conference takes place in New York and virtually, September 8-10, 2025. The company presentation will be available on demand as of Friday, September 5 at 7:00 A.M. (ET). Xtant’s management team will be available for virtual one-on-one meetings on September 8th.
Interested investors should contact their representative at H.C. Wainwright & Co., LLC. To register for the event and view the company’s presentation, visit: https://journey.ct.events/view/099ddf07-0cfd-43e7-b98f-ca41f0bc9d7f
See the news release at: https://investor.xtantmedical.com/news-releases/news-release-details/xtant-medical-participate-hc-wainwright-27th-annual-global
Xtant Medical is led by Chief Executive Officer Sean Browne, Chief Financial Officer Scott Neils, and Chief Operating Officer Mark Schallenberger, who bring extensive expertise in medical device commercialization, corporate finance, and orthobiologic innovation.
For more information, visit https://www.xtantmedical.com. Investor inquiries: Kevin Gardner at LifeSci Advisors,
[email protected].
Disclosure: David Shapiro, CEO of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted XTNT stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. This post is not intended to solicit the sale of XTNT or any security, and it is not intended to offer any opinion on XTNT as an investment. Conduct your own research and consult with your own professional advisors prior to making any investment decisions. See the complete Disclosure in the Risks and Disclosures section of https://b2idigital.com/disclaimer.
$OFIX $BVS